Chemoinformaics analysis of 2,4,6-trimethyl-3-oxo-5-indanacetic acid
| Molecular Weight | 232.279 | nRot | 2 |
| Heavy Atom Molecular Weight | 216.151 | nRig | 12 |
| Exact Molecular Weight | 232.11 | nRing | 2 |
| Solubility: LogS | -3.456 | nHRing | 0 |
| Solubility: LogP | 2.891 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 36.4547 |
| nHD | 1 | BPOL | 17.7873 |
| QED | 0.851 |
| Synth | 3.057 |
| Natural Product Likeliness | 1.509 |
| NR-PPAR-gamma | 0.972 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.009 |
| HIA | 0.004 |
| CACO-2 | -4.68 |
| MDCK | 0.000048 |
| BBB | 0.087 |
| PPB | 0.951758 |
| VDSS | 0.207 |
| FU | 0.0170396 |
| CYP1A2-inh | 0.284 |
| CYP1A2-sub | 0.647 |
| CYP2c19-inh | 0.04 |
| CYP2c19-sub | 0.796 |
| CYP2c9-inh | 0.033 |
| CYP2c9-sub | 0.853 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.267 |
| CYP3a4-inh | 0.036 |
| CYP3a4-sub | 0.322 |
| CL | 5.09 |
| T12 | 0.777 |
| hERG | 0.007 |
| Ames | 0.134 |
| ROA | 0.141 |
| SkinSen | 0.469 |
| Carcinogencity | 0.2 |
| EI | 0.101 |
| Respiratory | 0.634 |
| NR-Aromatase | 0.015 |
| Antiviral | No |
| Prediction | 0.595513 |